- Home
- CRON vs NEO Comparison
CRON vs NEO Comparison
Compare CRON & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRON | NEO |
|---|---|---|
| Founded | N/A | 2001 |
| Country | Canada | United States |
| Employees | N/A | 2500 |
| Industry | Medicinal Chemicals and Botanical Products | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 985.8M | 1.2B |
| IPO Year | 2015 | 2008 |
Fundamental Metrics
Financial Performance| Metric | CRON | NEO |
|---|---|---|
| Price | $2.73 | $9.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $13.38 |
| AVG Volume (30 Days) | 1.6M | ★ 2.0M |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $146,587,000.00 | N/A |
| Revenue This Year | $26.34 | $10.63 |
| Revenue Next Year | $15.53 | $9.73 |
| P/E Ratio | $68.38 | ★ N/A |
| Revenue Growth | ★ 24.63 | N/A |
| 52 Week Low | $1.84 | $4.72 |
| 52 Week High | $3.43 | $13.74 |
Technical Indicators
Market Signals| Indicator | CRON | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 53.81 | 60.46 |
| Support Level | $2.47 | $7.42 |
| Resistance Level | $2.72 | $10.82 |
| Average True Range (ATR) | 0.10 | 0.40 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 39.23 | 89.45 |
Price Performance
Historical ComparisonAbout CRON Cronos Group Inc.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.